Results 181 to 190 of about 45,170 (239)

Neuraminidase escape attempts

Nature Microbiology, 2019
Influenza vaccine strain selection is informed by international efforts to track antigenic change, focusing on the viral hemagglutinin protein. Recent research advocates monitoring neuraminidase for immune escape mutations that could reduce vaccine efficacy.
Annette, Fox, Louise, Carolan
openaire   +2 more sources

Human liver neuraminidase

Biochemical and Biophysical Research Communications, 1981
Two neuraminidase activities have been found in normal human liver, one soluble and the other particulate and essentially bound to the lysosomes. With storage of the liver at −80°C, no loss of either type of activity was noted for up to a year. KCl extracts of the soluble enzyme were stable for 15 days when stored in liquid nitrogen. For the sediments (
D M, Meyer, M, Lemonnier, R, Bourrillon
openaire   +2 more sources

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance

Journal of Clinical Virology, 2008
Influenza constitutes one of the most important upper respiratory tract infections regarding morbidity, and mortality. Prevention and treatment of influenza rely on inactivated vaccines and antiviral drugs. Zanamivir and Oseltamivir, the currently available influenza neuraminidase inhibitors (NAI) can be used in clinical practice for the treatment of ...
Olivier, Ferraris, Bruno, Lina
openaire   +2 more sources

Neuraminidase Gangliosides Interactions

1978
Gangliosides are sialoglycolipids containing one hydrophilic (the acidic oligosaccharide) and one hydrophobic (the N-acylsphingosine) portion. Due to this chemical property they behave, in water, as soluble amphiphilic compounds and occur as free molecules (monomers), below a certain concentration, and as aggregates (micelles) over that concentration ...
G, Tettamanti   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy